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Abstract
Background: pIREShyg2 has been widely used as a bicistronic expression vector. However, it is not known if the vector 
would affect the expression of cloned genes via nonsense-mediated mRNA decay (NMD), an mRNA surveillance 
system that degrades mRNA with a premature termination codon (PTC). In mammalian cells, the induction of NMD 
requires either a long 3'UTR or the presence of an exon-junction complex downstream of a PTC. The efficiency of NMD 
is greater when a PTC generates longer 3'UTR. pIREShyg2 provides the first cistron gene with a long 3'UTR consisting of 
a downstream intervening sequence (IVS), an internal ribosomal entry site (IRES) and the second cistron. Therefore, we 
hypothesized that the first cistron genes in pIREShyg2 are sensitized to NMD, which affects their expression levels. To 
examine this hypothesis, cDNAs encoding human granulocyte-macrophage colony-stimulating factor receptor β 
chain (βc) and its splice variant (βc79), in which the retention of a 79-base intron caused a frameshift generating 18 
PTCs, were cloned into pIREShyg2 and stably expressed in a murine cell line, Ba/F3.
Results: Compared with wild-type βc, the mRNA levels of βc79 were less than one tenth and decayed faster. Both 
translation inhibition and Upf1 knockdown led to significantly greater up-regulation of βc79 than wild-type βc. 
However, the use of a monocistronic pMT21 vector abolished the up-regulatory effects of translation inhibition and 
Upf1 knockdown on both wild-type βc and βc79, suggesting that the NMD is attributable to a structural determinant 
in pIREShyg2. The elimination of the intron and the proximal 3' 17 PTCs did not alter the greater effects of translation 
inhibition on βc79, suggesting that the first PTC, which determines 3'UTR length, was sufficient to enhance NMD 
efficiency. Thus, transcripts of PTC-harboring genes with longer 3'UTR are more efficiently degraded by the vector-
dependent NMD than those of wild-type genes with relatively shorter 3'UTR, resulting in minimized expression of 
truncated mutants.
Conclusions: We conclude that pIREShyg2, which sensitizes its bicistronic transcripts to NMD, may be useful for 
studying NMD but should be avoided when maximum expressions of PTC-harboring genes are required.
Background
Expression vectors containing an internal ribosome entry
site (IRES) element have been widely used as bicistronic
vectors that provide co-expression of two unrelated read-
ing frames from a single transcript unit [1-6]. A reading
frame in a multiple cloning site downstream of a pro-
moter is called the first cistron, and the second cistron is
downstream of an IRES element. pIREShyg2 is a bicis-
tronic expression vector that possesses an intervening
sequence (IVS) between the first cistron and an IRES ele-
ment derived from encephalomyocarditis virus, and a
hygromycin resistance gene in the second cistron, which
serves as a selection marker for stable transfection. It has
been shown that the first cistron gene is expressed at lev-
els comparable to those achieved in a monocistronic vec-
tor and initiation of translation is cap-dependent [7].
However, the present study is the first to show that the
use of pIREShyg2 affects the mRNA stability of their car-
rying genes in mammalian cells, potentially leading to
their insufficient expression.
Nonsense-mediated mRNA decay (NMD) is a post-
transcriptional mRNA quality control system that elimi-
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nates aberrant mRNAs harboring premature termination
codons (PTCs) within protein coding regions in eukary-
otes [8-10] to protect the cells from accumulation of
harmful or nonfunctional C-terminally truncated poly-
peptides [11,12]. The degradation occurs in a translation-
dependent manner when translation is initiated in an
mRNA cap-dependent manner [13,14]. In mammalian
cells, two determinants have been identified that distin-
guish "premature" termination codons from "normal" ter-
mination codons and provide a protective advantage to
the normal termination codon [15]. One is the presence
of an exon-junction complex (EJC) more than 50 nucle-
otides downstream of a termination codon [16-23].
Induction of NMD requires the association between the
EJC and the protein complex bound to the ribosome
stalled at a PTC, which contains essential proteins to trig-
ger NMD such as Upf1, eukaryotic release factors, and
SMG1 [13,24-28]. Because normal termination codons
generally reside either in the final exon or within 50
nucleotides upstream of the 3'-end in the penultimate
exon, the transcripts coding wild-type proteins are able to
escape NMD [16,29]. Another determinant is the dis-
tance between the stop codon and a poly(A) region [30-
33]. Normal termination requires the interaction between
the terminating ribosomal complex and the poly(A)-
binding proteins (PABP), which leads to faster release of a
terminating ribosome from mRNA [34]. A ribosomal
complex at a PTC fails to interact with PABPs because of
the relatively longer distance from the poly(A) region,
resulting in prolonged association with mRNA, which
stimulates NMD [28]. Recently, it has been reported that
the length between a termination codon and poly(A)
region affects NMD efficiency, showing that longer
3'UTR induces greater NMD activity [30-32].
Recently, we identified a novel splice variant of the
granulocyte-macrophage colony-stimulating factor
receptor (GMR) β chain (βc) in patients with myelodys-
plastic syndrome, a clonal hematopoietic disorder [35].
The splice variant (βc79) retained the 79-base intron V,
resulting in a frameshift that introduced eighteen PTCs
downstream of the retained intron. When the cDNAs
encoding the βc79 or wild-type βc were cloned into the
first cistron of pIREShyg2 vector and stably expressed in a
murine hematopoietic cell line, Ba/F3, βc79 mRNA levels
were significantly reduced compared with those observed
for wild-type βc. We show here that the pIREShyg2 vec-
tor sensitizes the first cistron genes to NMD and, inter-
estingly, that βc79 with PTCs was far more sensitive to
the vector-dependent NMD resulting in minimized
expression levels of the PTC-harboring gene.
Results
Intron V is not spliced out in βc79 clones
To determine whether the intron V was spliced in the
cells stably expressing βc79, we analyzed the presence of
intron V in the integrated DNA and respective RNA iso-
lated from each clone by PCR. The locations of the
sequences corresponding to the primers are shown in
Figure 1 and Table 1. PCR with 2S/2A primers that flank
intron V distinguished βc79 cDNA from wild-type βc
cDNA by the larger fragment size (446 bp versus 387 bp)
(Figure 2a). In RNA from all βc79 clones, only the larger
size of PCR products was detectable. The absence of a
387-bp band suggested that intron V in βc79 mRNA was
not spliced out in Ba/F3 transfectants resulting in the
generation of 18 PTCs. The unspliced intron V in βc79
mRNA was also detected by PCR using a 3S primer that
was complementary to the 5'-end of intron V. All RNA
samples without reverse transcription failed to generate
any PCR products (data not shown).
βc79 mRNA decays faster than wild-type βc mRNA
We determined the amounts of integrated DNA and
respective transcripts for wild-type βc or βc79 by real-
time PCR with 1S/1A primers. Compared with a clone
expressing wild-type βc 5C, βc79 clones mE and m821
Table 1: Sequences of primers.
Primer Sequence (5'T 3') Nucleotide position
1S TACCTGTGTCTGCCTGCTG 1910-1928 in βc
1A GAGACATAACCAGAGGCCACT 2136-2166 in βc
2S TGCCAGAGTTTTGTCGTCAC 326-345 in βc
2A CTTGCTGGGACGTCCTGAGA 692-712 in βc
3S CTTGGGAGGTAGGAACCACG 570-(i)12* in βc
HygRS TGGATATGTCCTGCGGGTAA 2073-2092 in IREShyg2
HygRA TTCCTTGCGGTCCGAATG 2345-2362 in IREShyg2
EpoRS CCACTGCTTACTGGCTTATCG 838-859 in IREShyg2
EpoRA TGCTCTCAAACTTGGGGTCCG 119-139 in EpoR
*(i), the nucleotide position in the intron V-derived sequenceShikama et al. BMC Molecular Biology 2010, 11:42
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had similar amounts of integrated βc79 cDNA, and about
half of that amount was found in clones m951 and 63m
(data not shown). However, as shown in Figure 2b, in all
four βc79 clones, RNA levels for βc79 were less than 10%
of that measured for wild-type βc mRNA in 5C. Two
other independent clones of wild-type βc, C10E and
FC10, showed higher mRNA levels than 5C. We next
added 5,6-dichlorobenzimidazolen1-β-D-ribofuranoside
(DRB), a transcription inhibitor, to mE and 5C cells and
determined the steady-state amounts of wild-type βc and
βc79 transcripts over time. Wild-type transcripts (relative
to GAPDH) decreased to 50% of the initial level after two
hours, while βc79 transcripts (relative to GAPDH) in mE
fell to half the initial level after one hour (Figure 2c). The
reduction of βc79 transcripts was significantly greater
than that of wild-type βc at the two and three hour time
points. Given that intron V was not spliced out in Ba/F3
transfectants, we hypothesized that the presence of 18
PTCs in βc79 mRNA upstream of the pIREShyg2-derived
IVS resulted in NMD induction.
Upregulation of βc79 transcripts by a translation inhibitor 
is greater than that of wild-type βc
It was shown that the treatment of cells with translation
inhibitors result in abrogation of NMD that occurs in a
translation-dependent manner [36,37]. Therefore, to
examine whether NMD is implicated in the degradation
of βc79 mRNA, mE cells were incubated with various
concentrations of puromycin, a translation inhibitor. The
amounts of βc79 transcripts relative to those of GAPDH
increased in a dose-dependent manner, and the maxi-
mum level (30.3 ± 1.4-fold) was observed with 20 μg/mL
puromycin (Figure 3). Emetin and cycloheximide (CHX),
two other inhibitors, also induced a dose-dependent
increase in βc79 transcripts and maximum effects similar
to those induced by puromycin (31.0 ± 7.0-fold, and 35.0
± 1.4-fold, respectively) (Figure 3).
To compare the effects of the translation inhibitor
between βc79 and wild-type βc, mE and 63m clones
expressing βc79 and clone 5C expressing wild-type βc
were incubated with 100 μg/mL puromycin, and βc-spe-
cific transcripts were quantified at various time points
(Figure 4a). A time-dependent increase in βc-specific
transcripts was observed in all three clones. At 4.5 hour
time point, the increase of βc79 transcripts in both mE
(41.4 ± 6.2-fold, p < 0.05) and 63m (39.6 ± 5.4-fold, p <
0.05) became significantly greater than that of wild-type
transcripts in 5C (11.4 ± 1.3-fold). The different up-regu-
latory response between βc79 and wild-type βc was con-
firmed in two other clones of βc79 and wild-type βc
Figure 1 Schematic presentation of wild-type βc- and βc79-con-
structs and positions of PCR primers. βc cDNA from exon II to exon 
XIV, which contains the full length of the protein coding region, was in-
serted into a pIREShyg2 vector that had an IVS, an internal ribosome 
entry site (IRES), and hygromycin resistance gene between its cloning 
site and poly(A) region. The distance from the normal stop codon in 
wild-type βc to the IVS was 254 nucleotides. The retention of 79-base 
intron V in βc79 caused a frameshift that generated 18 PTCs. The first 
termination codon in βc79 was "TGA". Hygr: hygromycin resistance 
gene, PCMV: human cytomegalovirus major immediate early promoter/
enhancer.
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Figure 2 DNA and RNA expression of introduced bc. (a) DNA and 
RNA were isolated from a wild-type βc-transfected clone 5C and four 
βc79-transfected clones mE, m821, m951, and 63m. The isolated DNA 
and reverse-transcribed RNA were subjected to the amplification of βc 
and GAPDH by PCR. Primers 1S/1A, 2S/2A, and 3S/2A were used for de-
tection of βc. cDNA obtained from 5C was diluted by 10 times, while 
cDNA from βc79-expressing clones were directly applied to PCR with-
out dilution. M: Marker. (b) The βc-specific transcripts were quantified 
by real-time PCR using primer 1S/1A. The amounts of βc-specific tran-
scripts relative to those of endogenous GAPDH transcripts were com-
pared among three wild-type and four βc79 clones. The average 
values from 3 runs of real-time RT-PCR are presented. Error bars express 
S.E.M. (c) The mE and 5C cells were cultured in the presence of 25 μg/
mL DRB and the ratios of βc-specific transcripts to GAPDH transcripts 
were plotted at various time points. *: significantly lower than the ratio 
from 5C cells at the same time points (p < 0.05).
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(Table 2). Among four βc79-expressing clones, there was
no significant difference in the increase of βc79 tran-
scripts induced by puromycin. After treatment for 8
hours, the βc79 mRNA levels in mE and 63m further
increased to 184.3 ± 27.9-fold and 115.7 ± 8.0-fold,
respectively. In contrast, there was only an 11.9 ± 2.9-fold
increase in wild-type βc transcripts in 5C. The resulting
mRNA levels of βc79 in mE and 63m became 66% and
26% of wild-type βc, respectively (Figure 4b).
To confirm that the effects of NMD inhibition were
greater on βc79 than on wild-type βc, siRNA targeting
Upf1, an essential component of the NMD machinery,
was used in mE and 5C cells. In both Upf1 siRNA-treated
mE and 5C cells, the Upf1 RNA levels became 25-30%
those of the control siRNA-treated cells after 24 hours,
and 50-55% after 48 hours. As shown in Figure 4c, the
reduction in Upf1 for 48 hours resulted in a 3.5 ± 0.4-fold
up-regulation of βc79 transcripts in mE, which was sig-
Figure 3 Dose-response relationship between βc79 transcripts 
and translation inhibitors. The βc79-expressing clone mE was incu-
bated with various concentrations of puromycin, emetin, and CHX for 
4.5 hours. The ratios of βc-specific transcripts to GAPDH transcripts 
were measured by real-time RT-PCR with 1S/1A primers. The ratios in 
NMD inhibitor-treated cells were divided by those in untreated cells, 
which are presented as fold increases. The mean values ± S.E.M. (error 
bars) were obtained from 3 to 4 independent experiments.
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Table 2: Effects of incubation with 100 μg/ml puromycin for 4.5 hours.
Wild-type βc clones Increase (-fold) βc79 clones Increase (-fold)
5C 11.4 ± 1.3 mE 41.4 ± 6.2
C10E 9.6 ± 1.5 63 m 39.6 ± 5.4
FC10 7.3 ± 0.7 m821 33.3 ± 1.2
m951 49.6 ± 3.2
Presented as average values and S.E.M. from three to eight independent experiments
Figure 4 Time course of βc transcript levels in response to puro-
mycin. (a) Two βc79 clones, mE and 63m, and a wild-type βc clone 5C 
were incubated with 100 μg/mL puromycin for the indicated periods, 
and the ratios of βc-specific transcripts to endogenous GAPDH tran-
scripts were measured by real-time RT-PCR with 1S/1A primers. The 
values at 0 hours are plotted as 1.0. The average values ± S.E.M. (error 
bars) were obtained from 3 to 8 experiments. * and **: significantly 
higher than the value in 5C incubated for the same time with p < 0.05 
and p < 0.01, respectively. (b) After 8-hour treatment, the βc-specific 
transcripts were quantified and normalized by those of GAPDH. The 
values from mE and 63m cells were compared with those from 5C cells, 
which are plotted as 1.0. (c) The siRNA targeting Upf1 was introduced 
into 5C and mE cells, and the amounts of Upf1 and βc transcripts were 
quantified after 48 hours. The presented data are the average values 
and S. E. M. (error bars) f3rom four different experiments. *: significantly 
different (p < 0.05).
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nificantly greater than that of wild-type βc in 5C (1.9 ±
0.2-fold, p < 0.05).
Vector sensitizes both wild-type βc and βc79 to NMD
Although wild-type βc transcripts were less affected by
NMD inhibition than βc79 transcripts, treatment with
puromycin always resulted in a 7 to 12-fold increase in
the amount of wild-type βc transcripts in Ba/F3 cells.
Interestingly, pIREShyg2 provides an IVS, an IRES and a
hygromycin resistance gene downstream of the normal
termination codon in wild-type βc. We wondered
whether the structural characteristics of pIREShyg2
might cause NMD in wild-type βc. To test this hypothe-
sis, cDNA of the wild-type βc was cloned into a monocis-
tronic pMT21 vector that did not have them between its
cloning site and poly(A) region (Figure 5a), and stably
expressed in Ba/F3 cells. In contrast to what we observed
when βc was cloned into pIREShyg2 (11.4 ± 1.3-fold
increase), transcripts of wild-type βc cloned into pMT21
showed only a slight increase (1.4 ± 0.2-fold) after incuba-
tion with puromycin for 4.5 hours. This difference was
highly significant (p < 0.01) (Figure 5b). The siRNA-
mediated Upf1 knockdown also resulted in a 0.81 ± 0.02-
fold change in the wild-type βc in pMT21, which was sig-
nificantly lower than that in pIREShyg2 (1.8 ± 0.2-fold, p
< 0.05) (Figure 5c). When βc79 was cloned into pMT21
instead of pIREShyg2, the up-regulatory response of βc79
diminished to 1.9 ± 0.2-fold, which was not significantly
different from that of wild-type βc cloned into pMT21
(Figure 5b).
We next examined whether pIREShyg2-dependent
NMD affected the expression of the second cistron. The
transcripts of hygromycin resistance gene (HygR) in the
cells expressing wild-type βc was increased 8.7 ± 1.6-fold
(n = 4) by puromycin treatment for 4.5 hours. The
increase of HygR transcripts in βc79 clones was 39.7 ±
1.3-fold (n = 3), which was significantly greater than that
in wild-type cells (P < 0.05).
Replacement of intron V with a single nucleotide or 
elimination of the intron preserving a 5' single PTC fail to 
alter NMD effects on βc79
To examine whether the greater NMD activity on βc79
was attributable to intron V retained in βc79, the 79
nucleotides of intron V were replaced by a single guany-
late residue as indicated by "G" in Figure 6a. Although the
78 nucleotides of the intronic sequence had been deleted
in the resulting cDNA (βc-G), βc-G still retained the same
18 PTCs as βc79 (Figure 6a). βc-G was cloned into
IREShyg2 and stably expressed in Ba/F3 cells. As shown
in Figure 6b, puromycin treatment for 4.5 hours
increased βc-G transcripts 38.6 ± 2.0-fold, which was sig-
nificantly higher than the increase in 5C (p < 0.05) but
not different from that in mE (41.4 ± 5.4-fold). This result
suggests that the presence of intron V per se is not
directly involved in mediating greater NMD on βc79 than
on wild-type βc. We next wanted to test whether preser-
vation of the first PTC mutation (position 259) in a vari-
ant of βc79 in which intron V had been completely
deleted still conferred NMD to the expressed transcripts
(Figure 6a). The resulting cDNA, βc258, was stably
expressed using pIREShyg2. The up-regulatory effect of
puromycin on βc258 (41.6 ± 10.9-fold) was not signifi-
cantly different from that on βc79 (Figure 6b).
Lastly, we examined whether the pIREShyg2-depen-
dent NMD was specific to βc. cDNAs of the wild type and
a truncated form (EpoR215) of mouse erythropoietin
receptor (EpoR), which are shown in Figure 6c, were sub-
cloned into pIREShyg2 and stably expressed in Ba/F3.
The puromycin treatment for 4.5 hours increased wild-
type EpoR transcripts 12.8 ± 1.9-fold. In contrast,
EpoR215 was increased 84.8 ± 16.5-fold, which was sig-
Figure 5 Effects of puromycin and Upf1 knockdown on the con-
structs cloned in a pMT21 vector. (a) The structure of the pMT21 vec-
tor. SV40ori: simian virus 40 (SV40) origin of replication and enhancer 
element; AdMLP: adenovirus major late promoter; TPL: the tripartite 
leader; IVS: intervening sequence; DHFR: murine dihydrofolate re-
ductase coding region; poly(A), polyadenylation signal. (b) The cDNAs 
of wild-type βc and βc79 were stably expressed in Ba/F3 cells using a 
pMT21 vector. These transfectants and 5C cells that expressed the 
wild-type βc in pIREShyg2 were incubated with or without 100 μg/mL 
puromycin for 4.5 hours. The values for βc/GAPDH in puromycin-treat-
ed cells were divided by the values in untreated cells, which are pre-
sented as fold increases of βc/GAPDH. Data shown are the average 
values ± S.E.M. (error bars) (pIREShyg2: n = 8, pMT21: n = 3). **: signifi-
cantly smaller than the value in the wild-type βc cloned into pIREShyg2 
(p < 0.01). (c) Upf1 was knocked down by siRNA in the cells expressing 
wild-type βc in pIREShyg2 (5C) and pMT21. The amounts of Upf1 and 
βc transcripts relative to GAPDH from three independent experiments 
are presented. *: significantly different (p < 0.05).
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nificantly greater than that of wild type (p < 0.05). (Figure
6d).
Discussion
This study reveals that an expression vector can destabi-
lize the mRNA of its carrying gene via NMD resulting in
minimized expression levels.
When βc79 and wild-type βc were stably expressed
using a commercial expression vector, pIREShyg2, the
mRNA levels of βc79 were less than one tenth those of
wild-type βc. mRNA expression levels are regulated
through transcriptional and posttranscriptional control
mechanisms [36-38], and mRNA stability is determined
by posttranscriptional regulation, which varies from one
mRNA species to another [39,40]. The diversity in the
transcriptional activities can be due to their integration
sites [41,42]. However, the low βc79 expression was uni-
formly seen in all clones tested, and the transcripts of
βc79 decayed faster than those of wild-type βc. These
indicate that the posttranscriptional mechanism was
involved in the low expression levels of βc79 mRNA. The
RT-PCR indicated that 79-base intron V was retained in
the βc79 transcripts, generating 18 PTCs and longer 3'
UTR in βc79 than in wild-type. Since transcripts with
longer 3'UTR are more sensitive to NMD in mammalian
cells [30-33], we examined whether destabilization of
βc79 mRNA via NMD caused the suppression of βc79
expression levels.
The faster decay of βc79 mRNA is attributable to
greater effects of NMD on βc79 than on wild-type βc.
Since NMD is a translation-dependent process, transla-
tion inhibitors have been used to abrogate NMD, and the
increase in mRNA levels in the presence of a translation
inhibitor is considered to reflect the effects of NMD
[43,44]. The up-regulation of βc79 transcripts by three
different translation inhibitors indicated that βc79 mRNA
was degraded by NMD. Furthermore, the up-regulatory
effects of the translation inhibition were significantly
greater on βc79 than on wild-type βc, which diminished
the difference in mRNA levels between βc79 and wild-
type βc. The greater effects of NMD on βc79 were also
confirmed by siRNA-mediated NMD inhibition. Tran-
scripts of βc79 were thus degraded more efficiently by
NMD than those of wild-type βc, which resulted in lower
mRNA levels of βc79.
Wild-type βc was also sensitive to NMD when
expressed by pIREShyg2, because both translation inhibi-
tion and Upf1 knockdown increased transcripts of wild-
t y p e  β c  c l o n e d  i n t o  p I R E S h y g 2 .  T h e s e  u p - r e g u l a t o r y
effects were abrogated when pMT21 was used instead of
pIREShyg2. This observation indicates that the vector
s e n s i t i z e d  w i l d - t y p e  β c  t o  N M D .  B e c a u s e  β c 7 9  a l s o
became insensitive to NMD in pMT21, we concluded
that the IRES vector rendered its first cistronic genes sen-
sitive to NMD.
There may be additional determinants for the stronger
NMD to βc79 in the pIREShyg2 system. Although the
nucleotide in the position immediately downstream of
the termination codon was shown to enhance the up-reg-
ulatory effects of translation inhibition in the order G <
U, A < C [45,46], it does not seem relevant to the differ-
ence between βc79 and the wild-type βc, because the
nucleotide following the first PTC in βc79 and the one
after the normal stop codon in wild-type βc are both G.
The replacement of the intron V with a single nucleotide
Figure 6 Replacement of the intron V with a single nucleotide. (a) 
βc-G was constructed by replacing the intron V-derived 79 nucleotides 
with a single nucleotide G in βc79. The frameshift generating eighteen 
PTCs were preserved in βc-G. βc258 was a βc with a single PTC at the 
259 th codon. Both βc79 and βc-G had 2238 nucleotides downstream 
of their termination codon, and βc258 had 2183 nucleotides. (b) βc-G 
and βc258 were cloned into a pIREShyg2 vector and stably expressed 
in Ba/F3 cells. The cells expressing βc-G, βc258, βc79 (mE) and wild-
type βc (5C) were cultured with or without 100 μg/mL puromycin for 
4.5 hours. The amounts of βc-specific transcripts relative to GAPDH 
transcripts in puromycin-treated cells were divided by the amounts in 
untreated cells, and are presented as-fold increases of βc/GAPDH. Av-
erage values and S.E.M. (error bars) were obtained from three indepen-
dent experiments. * significantly higher than 5C (p < 0.05). (c) EpoR215 
was an EpoR with a termination codon (TAG) at the 215 th codon gen-
erating 1099 nucleotides downstram of the termination codon. In 
wild-type EpoR, there were 190 nucleotides downstream of its normal 
termination codon. (d) Wild-type EpoR and EpoR215 were stably ex-
pressed in Ba/F3 cells using a pIREShyg2 vector, and cultured with or 
without 100 μg/ml puromycin for 4.5 hours. The ratios of EpoR-specific 
transcripts to GAPDH transcripts in puromycin-treated cells were divid-
ed by those in untreated cells. Average values and S. E. M. (error bars) 
were obtained from three different experiments. * significantly higher 
than the value in wild-type EpoR (P < 0.05).
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did not alter the up-regulatory effects of NMD inhibition,
suggesting that the intron V was not responsible for
greater NMD effects on βc79. The βc258, which had a
single PTC at a position similar to the distal 5' PTC in
βc79 but no frameshift, elicited a degree of NMD similar
to that of βc79, indicating that the 5' single PTC is suffi-
cient to induce greater NMD effects on βc79. This is
comparable to recent reports in which more efficient
NMD was induced when a PTC was generated closer to
5'-end resulting in longer 3'UTR length [30-32].
Lastly, it is unlikely that pIREShyg2-related NMD
induction is specific to βc cDNA. When wild-type EpoR
was stably expressed in the same cell line using
pIREShyg2, upregulation of its transcripts was induced
by puromycin, suggesting that wild-type EpoR in
pIREShyg2 vector was also a target of NMD. The effects
of puromycin were enhanced on EpoR215 that possessed
longer 3'UTR.
Thus, the expression levels of genes encoding truncated
mutants, in which PTCs generate longer 3'UTRs, can be
significantly reduced via vector-dependent NMD com-
pared with wild-type genes that generally have shorter
3'UTR.
Conclusions
We show here for the first time the NMD effects associ-
ated with an expression vector in a mouse hematopoietic
cell line. Although the IRES vector may be an interesting
system for studying NMD, our study warns us that the
choice of the IRES vector leads to undesirable conse-
quences especially when maximum expression of a trun-
cated mutant with a long 3'UTR is required in
mammalian cells.
Methods
Plasmid constructions
The cDNA of full-length GM-CSF receptor βc subunit
(kindly provided by Dr. Sumiko Watanabe, University of
Tokyo, Tokyo, Japan) was subcloned into the SmaI site of
pIREShyg2, an expression vector (Clontech Laboratories,
Inc., Palo Alto, USA), as shown in Figure 1. The βc79
cDNA containing intron V at nucleotide position 578 was
isolated from a patient with myelodysplastic syndromes
and subcloned into a plasmid vector, pCR4-TOPO (Invit-
rogen Corp, Carlsbad, USA) to confirm its sequence. The
Acc I site to BssH II fragment of βc79, which contains
intron V, was used to replace the Acc I-BssH II fragment
of wild-type βc in pIREShyg2, thus generating the βc79-
IREShyg2 construct.
Wild-type βc in pMT21 was obtained using the con-
struct of the EpoR-βc hybrid receptor in pMT21, which
was prepared in a previous study [47]. The hybrid recep-
tor consisted of 756 bases proximal to 5' of EpoR cDNA
and 1655 bases proximal to 3' of βc cDNA. The fragment
between EcoRI and BssHII sites of the hybrid receptor in
pMT21, which contained the EpoR-coding region, was
substituted to cDNA of wild-type βc or βc79 in
pcDNA3.1 that possessed an EcoRI site in the multiple
cloning region. The obtained full-length βc cDNA in
pMT21was sequenced prior to transfection.
cDNA of murine EpoR, a generous gift from Dr. Alan
D'Andrea (Dana-Farber Cancer Institute, Boston, USA),
was inserted between Eco47III and EcoRV sites in
pIREShyg2 vector.
The constructs harboring a single PTC were generated
using QuickCHange II XL Site-Directed Mutagenesis Kit
(Stratagen-An Agilent Technologies Company, La Jolla,
USA), and sequenced prior to transfection.
Transfection
The constructs were introduced into Ba/F3 cells, an IL-3-
dependent mouse hematopoietic progenitor cell line, as
described previously [35]. The hygromycin-resistant cells
were subjected to repeated limiting dilutions to establish
independent clones.
Inhibitions of transcription and translation
Cells (grown at 1 × 106 cells/ml) were cultured in the
presence of 25 μg/mL DRB (Sigma-Aldrich Corp., St.
Louis, MO), a transcription inhibitor, or the indicated
concentrations of translation inhibitors: emetin (Sigma),
puromycin (Sigma), or CHX (Sigma).
Upf1 knockdown by siRNA induction
The siRNA corresponding to mouse Upf1 mRNA was
designed as follows: sense GAUGCAGUUCCGUUCCA-
CUtt and antisense GAUGGAACGGAACUGCAUCtt
(nucleotide 2084-2102; Genbank Accession No.
AY597038). One and a half μg control siRNA (Ambion
Inc., Austin, USA) or siRNA targeting to Upf1 was intro-
duced into 0.2 × 105 cells suspended in 75 μL siPORT™
siRNA Electroporation Buffer (Ambion) by square-pulse
electroporation (250 mV 30 msec) using a Gene Pulser
(Bio-Rad Laboratories, Inc., Hercules, USA). After 24 and
48 hours, the transcripts of βc and Upf1 were quantified.
Isolation of DNA and RNA
Genomic DNA was isolated from each clone using the
Generation DNA purification system kit (Gentra Sys-
tems, Inc., Minneapolis, MN). Total cellular RNA was
isolated by acid guanidium thiocyanate-phenol-chloro-
form extraction methods [48]. All RNA samples were
treated with RNase-free DNaseI (Takara Bio, Inc., Otsu,
Japan) prior to further analyses.
PCR, and real-time PCR
The total cellular RNA was incubated in reverse-tran-
scription buffer including random primer, dNTP, and
RNAase inhibitor, with or without reverse transcriptaseShikama et al. BMC Molecular Biology 2010, 11:42
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at 37°C for 1 hour as previously described [49], and sub-
jected to PCR analyses. The annealing temperatures for
detection of βc and others were 62°C and 56°C, respec-
tively. The samples prepared without the enzyme were
used to examine DNA contamination in the RNA sam-
ples. The sequences of PCR primers are presented in
Table 1.
The βc-specific transcripts were quantified by real-time
PCR in duplicate using SYBR Premix Ex Taq (Takara Bio.
Inc.), 1S/1A primers (Table 1), and LightCycler (Roche
Diagnostics GmbH, Mannheim, Germany). Glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) was also
quantified as an internal control. The real-time PCR pro-
tocol included an initial denaturing step at 95°C for 30
seconds, 40 cycles of 5-second denaturing, 10-seccond
annealing and 15-second extension, a cooling step to
65°C for 15 seconds followed by a heating step for dissoci-
ation analysis. The annealing temperatures for quantifi-
cation of βc and others were 62°C and 56°C, respectively.
Crossing points were determined by the second deriva-
tive maximum method. The amounts of targets were cal-
culated based on standard curves which were generated
by the amplification of sequentially diluted cDNA with
each PCR primer pair. In every experiment, it was con-
firmed that the first derivatives of the dissociation curves
had only a single peak.
Statistical analysis
The comparison of data among more than three clones
was done by Scheffe's test. The Mann-Whitney test was
used for the comparison between two groups.
Authors' contributions
YS conceived and designed the study. YS and HH quantified transcripts. YS, HH,
and MO constructed a mutant cDNAs. IM and JK supervised the study design
and data analyses. TS participated in the identification of the variant and the
preparation of the manuscript. All authors read and approved the final manu-
script.
Acknowledgements
We thank Dr. Ikuo Wada (Fukushima Medical University, Fukushima, Japan) for 
constructive comments and technical support for transfection experiments, Dr. 
Bernard Mathey-Prevot (Duke University School of Medicine, Durham, USA) 
and Dr. Yuichi Endo (Fukushima Medical University) for helpful advice in the 
preparation of the manuscript, Dr. Midori Yatabe (Fukushima Medical Univer-
sity) for the correction of English, Dr. Tomoyuki Ono and Ms. Sanae Sato (Fuku-
shima Medical University) for technical assistance. This work was supported by 
the Fukushima Medical Research Fund (Japan), NISHINOMIYA Basic Research 
Fund (Japan), and a grant from the Smoking Research Foundation (Japan).
Author Details
1Department of Pharmacology, Fukushima Medical University, Fukushima, 
Japan, 2Department of Pharmaceutical Toxicology, School of Pharmaceutical 
Sciences, China Medical University, Shenyang, China, 3The Laboratory of 
Pharmacology, Faculty of Pharmacy, Takasaki University of Health and Welfare, 
Takasaki, Japan, 4Department of Cardiology and Hematology, Fukushima 
Medical University, Fukushima, Japan and 5Fukushima Research Institute of 
Environment and Medicine, Futaba, Japan
References
1. Davies MV, Kaufman RJ: Internal translation initiation in the design of 
improved expression vectors.  Curr Opin Biotechnol 1992, 3:512-517.
2. Dirks W, Wirth M, Hauser H: Dicistronic transcription units for gene 
expression in mammalian cells.  Gene 1993, 128:247-249.
3. Mountford PS, Smith AG: Internal ribosome entry sites and dicistronic 
RNAs in mammalian transgenesis.  Trends Genet 1995, 11:179-184.
4. Borman AM, Bailly JL, Girard M, Kean KM: Picornavirus internal ribosome 
entry segments: comparison of translation efficiency and the 
requirements for optimal internal initiation of translation in vitro.  
Nucleic Acids Res 1995, 23:3656-3663.
5. Martinez-Salas E: Internal ribosome entry site biology and its use in 
expression vectors.  Curr Opin Biotechnol 1999, 10:458-464.
6. Fussenegger M, Bailey J, Hauser H, Mueller PP: Genetic optimization of 
recombinant glycoprotein production by mammalian cells.  Trends 
Biotechnol 1999, 17:35-42.
7. Hennecke M, Kwissa M, Metzger K, Oumard A, Kröger A, Schirmbeck R, 
Reimann J, Hauser H: Composition and arrangement of genes define 
the strength of IRES-driven translation in bicistronic mRNAs.  Nucleic 
Acids Res 2001, 29:3327-3334.
8. Behm-Ansmant I, Kashima I, Rehwinkel J, Sauliere J, Wittkopp N, Izaurralde 
E: mRNA quality control: an ancient machinery recognizes and 
degrades mRNAs with nonsense codons.  FEBS Lett 2007, 
581:2845-2853.
9. Chang YF, Imam JS, Wilkinson MF: The nonsense-mediated decay RNA 
surveillance pathway.  Annu Rev Biochem 2007, 76:51-74.
10. Isken O, Maquat LE: Quality control of eukaryotic mRNA: safeguarding 
cells from abnormal mRNA function.  Genes Dev 2007, 21:1833-1856.
11. Wilkinson MF: A new function for nonsense-mediated mRNA-decay 
factors.  Trends Genet 2005, 21:143-148.
12. Pan Q, Saltzman AL, Kim YK, Misquitta C, Shai O, Maquat LE, Frey BJ, 
Blencowe BJ: Quantitative microarray profiling provides evidence 
against widespread coupling of alternative splicing with nonsense-
mediated mRNA decay to control gene expression.  Genes Dev 2006, 
20:153-158.
13. Ishigaki Y, Li X, Serin G, Maquat LE: Evidence for a pioneer round of 
mRNA translation: mRNAs subject to nonsense-mediated decay in 
mammalian cells are bound by CBP80 and CBP20.  Cell 2001, 
106:607-617.
14. Sato H, Hosoda N, Maquat LE: Efficiency of the pioneer round of 
translation affects the cellular site of nonsense-mediated mRNA decay.  
Mol Cell 2008, 29:255-262.
15. Shyu AB, Wilkinson MF, van Hoof A: Messenger RNA regulation: to 
translate or to degrade.  EMBO J 2008, 27:471-481.
16. Nagy E, Maquat LE: A rule for termination-codon position within intron-
containing genes: when nonsense affects RNA abundance.  Trends 
Biochem Sci 1998, 23:198-199.
17. Carter MS, Li S, Wilkinson MF: A splicing-dependent regulatory 
mechanism that detects translation signals.  EMBO J 1996, 
15:5969-5975.
18. Zhang J, Sun X, Qian Y, LaDuca JP, Maquat LE: At least one intron is 
required for the nonsense-mediated decay of triosephosphate 
isomerase mRNA: a possible link between nuclear splicing and 
cytoplasmic translation.  Mol Cell Biol 1998, 18:5272-5283.
19. Neu-Yilik G, Gehring NH, Thermann R, Frede U, Hentze MW, Kulozik AE: 
Splicing and 3' end formation in the definition of nonsense-mediated 
decay-competent human beta-globin mRNPs.  EMBO J 2001, 
20:532-540.
20. Thermann R, Neu-Yilik G, Deters A, Frede U, Wehr K, Hagemeier C, Hentze 
MW, Kulozik AE: Binary specification of nonsense codons by splicing 
and cytoplasmic translation.  EMBO J 1998, 16:3484-3494.
21. Lykke-Andersen J, Shu MD, Steitz JA: Communication of the position of 
exon-exon junctions to the mRNA surveillance machinery by the 
protein RNPS1.  Science 2001, 293:1836-1839.
22. Maquat LE, Li X: Mammalian heat shock p70 and histone H14 
transcripts, which derive from naturally intronless genes, are immune 
to nonsense-mediated decay.  RNA 2001, 7:445-456.
23. Brocke KS, Neu-Yilik G, Gehring NH, Hentze MW, Kulozik AE: The human 
intronless melanocortin 4-receptor gene is NMD insensitive.  Hum Mol 
Genet 2002, 11:331-335.
24. Ohnishi T, Yamashita A, Kashima I, Schell T, Anders KR, Grimson A, Hachiya 
T, Hentze MW, Anderson P, Ohno S: Phosphorylation of hUPF1 induces 
Received: 1 June 2009 Accepted: 1 June 2010 
Published: 1 June 2010
This article is available from: http://www.biomedcentral.com/1471-2199/11/42 © 2010 Shikama et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. BMC Molecular Biology 2010, 11:42Shikama et al. BMC Molecular Biology 2010, 11:42
http://www.biomedcentral.com/1471-2199/11/42
Page 9 of 9
formation of mRNA surveillance complexes containing hSMG-5 and 
hSMG-7.  Mol Cell 2003, 12:1187-1200.
25. Gehring NH, Neu-Yilik G, Schell T, Hentze MW, Kulozik AE: Y14 and 
hUpf3b form an NMD-activating complex.  Mol Cell 2003, 11:939-949.
26. Palacios IM, Gatfield D, St Johnston D, Izaurralde E: An eIF4AIII-containing 
complex required for mRNA localization and nonsense-mediated 
mRNA decay.  Nature 2004, 427:753-757.
27. Kashima I, Yamashita A, Izumi N, Kataoka N, Morishita R, Hoshino S, Ohno 
M, Dreyfuss G, Ohno S: Binding of a novel SMG-1-Upf1-eRF1-eRF3 
complex (SURF) to the exon junction complex triggers Upf1 
phosphorylation and nonsense-mediated mRNA decay.  Genes Dev 
2006, 20:355-367.
28. Behm-Ansmant I, Izanrralde E: Quality control of gene expression: a 
stepwise assembly pathway for the surveillance complex that triggers 
nonsense-mediated mRNA decay.  Genes Dev 2006, 20:391-398.
29. Keeling KM, Lanier J, Du M, Salas-Marco J, Gao L, Kaenjak-Angeletti A, 
Bedwell DM: Leaky termination at premature stop codons antagonizes 
nonsense-mediated mRNA decay in S. cerevisiae.  RNA 2004, 10:691-703.
30. Bühler M, Steiner S, Mohn F, Paillusson A, Mühlemann O: EJC-
independent degradation of nonsense immunoglobulin-μ mRNA 
depends on 3' UTR length.  Nat Struct Mol Biol 2006, 13:462-464.
31. Behm-Ansmant I, Gatfield D, Rehwinkel J, Hilgers V, Izaurradle E: A 
conserved role for cytoplasmic poly(A)-binding protein 1 (PABC1) in 
nonsense-mediated mRNA decay.  EMBO J 2007, 26:1591-1601.
32. Longman D, Plasterk RH, Johnstone IL, Cáceres JF: Mechanistic insights 
and identification of two novel factors in the C. elegans NMD pathway.  
Genes Dev 2007, 21:1075-1085.
33. Eberle AB, Stalder L, Mathys H, Orozco RZ, Mühlemann O: 
Posttranscriptional gene regulation by spatial rearrangement of the 3' 
untranslated region.  PLoS Biol 2008, 6:849-859.
34. Amrani N, Ganesan R, Kervestin S, Mangus DA, Ghosh S, Jacobson A: A 
faux 3'-UTR promotes aberrant termination and triggers nonsense-
mediated mRNA decay.  Nature 2004, 432:112-118.
35. Shikama Y, Shichishima T, Matsuoka I, Jubinsky PT, Sieff CA, Maruyama Y: 
Accumulation of an intron-retained mRNA for granulocyte 
macrophage-colony stimulating factor receptor common β chain in 
neutrophils of myelodysplastic syndromes.  J Leukocyte Biol 2005, 
77:811-819.
36. Wang Y, Liu CL, Storey JD, Tibshirani RJ, Herschlag D, Brown PO: Precision 
and functional specificity in mRNA decay.  Proc Natl Acad Sci USA 2002, 
99:5860-5865.
37. Raghavan A, Ogilvie RL, Reilly C, Abelson ML, Raghavan S, Vasdewani J, 
Krathwohl M, Bohjanen PR: Genome-wide analysis of mRNA decay in 
resting and activated primary human T lymphocytes.  Nucleic Acids Res 
2002, 30:5529-5538.
38. Gutierrez RA, Ewing RM, Cherry JM, Green PJ: Identification of unstable 
transcripts in Arabidopsis by cDNA microarray analysis: rapid decay is 
associated with a group of touch- and specific clock-controlled genes.  
Proc Natl Acad Sci USA 2002, 99:11513-11518.
39. Mitchell P, Tollervey D: mRNA stability in eukaryotes.  Curr Opn Genet Dev 
2000, 10:193-198.
40. Wilusz CJ, Wormington M, Peltz SW: The cap-to-tail guide to mRNA 
turnover.  Nat Rev Mol Cell Biol 2001, 2:237-246.
41. Feng YQ, Lorincz MC, Fiering S, Greally JM, Bouhassira EE: Position effects 
are influenced by the orientation of a transgene with respect to 
flanking chromatin.  Mol Cell Biol 2001, 21:298-309.
42. Eszterhas SK, Bouhassira EE, Martin DI, Fiering S: Transcriptional 
interference by independently regulated genes occurs in any relative 
arrangement of the genes and is influenced by chromosomal 
integration position.  Mol Cell Biol 2002, 22:469-479.
43. Noensie EN, Dietz HC: A strategy for disease gene identification through 
nonsense-mediated mRNA decay inhibition.  Nat Biotech 2001, 
19:434-439.
44. Carter MS, Doskow J, Morris P, Li S, Nihm RP, Sandstedt S, Wilkinson MF: A 
regulatory mechanism that detects premature nonsense codons in T-
cells receptor transcripts in vivo is reversed by protein synthesis 
inhibitors in vitro.  J Biol Chem 1995, 270:28995-29003.
45. Bonetti B, Fu L, Moon J, Bedwell DM: The efficiency of translation 
termination is determined by a synergistic interplay between 
upstream and downstream sequences in Saccharomyces cerevisiae.  J 
Mol Biol 1995, 251:334-345.
46. Howard MT, Shirts BH, Petros LM, Flanigan KM, Gesteland RF, Arkins JF: 
Sequence specificity of aminoglycoside-induced stop codon 
readthrough: potential implications for treatment of Duchenne 
muscular dystrophy.  Ann Neurol 2000, 48:164-169.
47. Shikama Y, Barber DL, D'Andrea AD, Sieff CA: A constitutively activated 
chimeric cytokine receptor confers factor-independent growth in 
hematopoietic cell lines.  Blood 1996, 88:455-464.
48. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid 
guanidinium thiocyanate-phenol-chloroform extraction.  Anal Biochem 
1987, 162:156-159.
49. Hu H, Shikama Y, Matsuoka I, Kimura J: Terminally differentiated 
neutrophils predominantly express Survivin-2α, a dominant-negative 
isoform of Survivin.  J Leukocyte Biol 2008, 83:393-400.
doi: 10.1186/1471-2199-11-42
Cite this article as: Shikama et al., Transcripts expressed using a bicistronic 
vector pIREShyg2 are sensitized to nonsense-mediated mRNA decay BMC 
Molecular Biology 2010, 11:42